Pharming (PHAR) Operating Margin (2020 - 2026)
Pharming (PHAR) posted Operating Margin of 6.78% for Q1 2026, down 216.44% on a QoQ basis from 5.82% in Q4 2025, and up 213.0% year-over-year from 2.17% in Q1 2025.
Pharming (PHAR) Operating Margin (2020 - 2026) Analysis & Trends
Pharming's Operating Margin history runs 7 years deep, the most recent figure standing at 6.78% for Q1 2026.
- Quarterly Operating Margin rose 213.0% year-over-year to 6.78% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.41% (up 2489.0% YoY) and the FY2025 annual result came in at 6.87%, up 977.0% from the prior year.
- Operating Margin was 6.78% for Q1 2026 at Pharming, down from 5.82% in the prior quarter.
- Across five years, Operating Margin topped out at 5481283.42% in Q3 2024 and bottomed at 4215647.92% in Q4 2024.
- A 5-year average of 394411.38% and a median of 2.86% in 2023 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2024 — Operating Margin soared 548128056 bps — and 2025, when it tumbled 548126718 bps.
- Pharming's Operating Margin stood at 18.81% in 2022, then tumbled by 143 bps to 8.0% in 2023, then plunged by 52663071 bps to 4215647.92% in 2024, then jumped by 100 bps to 5.82% in 2025, then tumbled by 216 bps to 6.78% in 2026.
- Business Quant data shows PHAR's Operating Margin at 6.78% in Q1 2026, 5.82% in Q4 2025, and 16.24% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | -6.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.78% |
| Dec 31, 2025 | 5.82% |
| Sep 30, 2025 | 16.24% |
| Jun 30, 2025 | 2.21% |
| Mar 31, 2025 | -8.91% |
| Dec 31, 2024 | -4,215,647.92% |
| Sep 30, 2024 | 5,481,283.42% |
| Jun 30, 2024 | -14.99% |
| Mar 31, 2024 | -29.35% |
| Dec 31, 2023 | -8.00% |
| Sep 30, 2023 | 2.86% |
| Jun 30, 2023 | 5,439,356.31% |
| Mar 31, 2023 | -32.12% |
| Dec 31, 2022 | 18.81% |
| Sep 30, 2022 | 14.39% |
| Jun 30, 2022 | 35.53% |
| Mar 31, 2022 | 6.01% |
| Dec 31, 2021 | -12.35% |
| Sep 30, 2021 | -3.19% |
| Jun 30, 2021 | 21.86% |